Objective: Pharmacological options for treating bipolar disorder have increased over the
past 20 years, with several second-generation antipsychotics receiving regulatory approval�…

Background: The potential benefits of typical antipsychotic agents in bipolar disorder are
offset by serious treatment-associated side effects. Despite these concerns and the�…

OBJECTIVE: This study examined recent changes in the prescribing patterns for
medications to treat bipolar disorder in office-based psychiatric practice. METHOD: The�…

Objectives To understand treatment practices for bipolar disorders (BD), this study leveraged
the Global Bipolar Cohort collaborative network to investigate pharmacotherapeutic�…

Objective: Bipolar disorders are prevalent major illnesses with high rates of morbidity,
comorbidity, disability, and mortality. A growing number of psychotropic drugs are used to�…

Objective: Because treatments for bipolar disorder include a growing num-ber of
psychotropic agents, the authors evaluated psychotropic polytherapy and adherence to�…

Background Patients with bipolar disorder are exceptionally challenging to manage
because of the dynamic, chronic, and fluctuating nature of their disease. Typically, the�…

Objective The risk-benefit profile of antidepressant medications in bipolar disorder is
controversial. When conclusive evidence is lacking, expert consensus can guide treatment�…

Objective: This study assessed patterns of psychopharmacological treat-ment for bipolar
disorder. Method: Intake treatment data were examined for the first 500 patients in the�…

Relatively absent from previous studies of the pharmacotherapy for bipolar disorder is
examination of the impact of comorbidity on treatment choices. This has occurred despite the�…